Drugmaker Pfizer Inc said on Monday that it identified certain antiviral compounds it had in development that have the potential to inhibit coronaviruses and is engaging with a third party to screen the compounds. Pfizer Chief Scientific Officer Mikael Dolsten was one of a number of pharmaceutical executives who met with U.S. President Trump at the White House on Monday.
